课题基金 / 基金详情

STUDY ON THE EXPRESSION OF ESTROGEN RECEPTORS IN MALIGNANT RHABDOID TUMOR

STUDY ON THE EXPRESSION OF ESTROGEN RECEPTORS IN MALIGNANT RHABDOID TUMOR
恶性横纹肌瘤中雌激素受体表达的研究
批准号:
14570741
负责人:
OHTA Shigeru
金额:
$1.09万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

OHTA Shigeru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Expression of estrogen receptors and cytotoxic effects of the anti-estrogens on malignant rhabdoid tumor (MRT) cell lines were examined.Materials and Methods: Six cell lines of MRT(TM87-16, STM91-01, TTC549, TTC642, TTC1240 and YAM-RTK1) were used for the examination on the expression of estrogen receptor alpha(ERα), progesterone receptor which has some correlation to estrogen, and pS2. The effect of Tamoxifen(TAM) on the cell proliferation of MRT cell lines expressing ERα was examined. TAM has E2(estrogen) as well as anti-E2 effects. So the effect of ICI, which is a pure anti-estrogen, on the cellular proliferation of MRT cell lines was also checked.Results: The expression of ER-α was detected in TTC87-16, TTC642 and TTC1240. The expression of pS2 was not seen. The proliferation of these MRT cells was arrested with the addition of TAM and apoptosis was induced. Inhibition of cellular proliferation was note induced with ICI. The suppression of cellular proliferation was note improved with the simultaneous administration of TAM and E2.Discussion: Some of MRT cell lines expressed ER-α and showed the inhibition of cellular growth with TAM. This effect was delivered from the pathway other than ER-α. There will be a possible use of TAM as a agent for tumor dormancy therapy for MRT.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
太田 茂, 成田 努, 他: "Rhabdoid Tumor -基礎研究の最新知見"小児外科. 34. 440-445 (2002)
Shigeru Ota、Tsutomu Narita 等人:“横纹肌样肿瘤 - 基础研究的最新发现”小儿外科。 34. 440-445 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinobu Yoshida, Shigeru Ohta et al.: "TRAIL/Apo2L Ligands induce apoptosis in Malignant Rhabdoid Tumor cell lines."Pediatric Research. 54巻5号. 709-717 (2003)
Shinobu Yoshida、Shigeru Ohta 等人:“TRAIL/Apo2L 配体诱导恶性横纹肌瘤细胞系凋亡。”儿科研究,第 54 卷,第 5 期。709-717(2003 年)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirofumi Kato, Shigeru Ohta, et al.: "Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: Differentiation induction using 5-azacytidine"Cancer Science. 94:(10). 1059-1065 (2003)
Hirofumi Kato、Shigeru Ohta 等人:“恶性横纹肌样肿瘤细胞系中周细胞、系膜和肌肉标记物的表达:使用 5-氮杂胞苷进行分化诱导”癌症科学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
太田 茂, 成田 努, 他: "Rhabdoid Tumor...基礎研究の最新知見"小児外科. 34・4. 440-445 (2002)
Shigeru Ota、Tsutomu Narita 等:“横纹肌样肿瘤……基础研究的最新发现”34・4(2002 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Toxicities and pharmacokinetics of new chemical structures of designer drugs, and their prediction in humans
    • 批准号:
      18H03066
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2018
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    Prediction of interindividual differences of drug metabolism and pharmacokinetics using chimeric mice with humanized liver
    • 批准号:
      23659053
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    Pathogenetic mechanism of sporadic Parkinson's disease based on familial Parkinson's disease
    • 批准号:
      20390040
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2008
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    Drug development using novel animal model based on the pathogenesis of Parkinson' s disease-related disorders
    • 批准号:
      20406005
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.32万
    • 财政年份:
      2008
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    国内基金
    海外基金
    GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
    • 批准号:
      82371652
    • 项目类别:
      面上项目
    • 资助金额:
      45.00万元
    • 批准年份:
      2023
    • 负责人:
      刘开江
    • 依托单位:
    Estrogen/NDRG2/Na+/K+-ATPase调控通路在唾液生成和雌激素缺乏诱发口干症中的作用研究
    新型雌激素受体GPR30在乳腺癌中的作用及机制探讨
    • 批准号:
      30872520
    • 项目类别:
      面上项目
    • 资助金额:
      28.0万元
    • 批准年份:
      2008
    • 负责人:
      涂刚
    • 依托单位:
    雌激素调控子宫内膜异位症病灶神经产生致疼痛的机理研究
    • 批准号:
      30872754
    • 项目类别:
      面上项目
    • 资助金额:
      8.0万元
    • 批准年份:
      2008
    • 负责人:
      张信美
    • 依托单位: